Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px
Person › Details

Tim Knorr (Rittershaus Rechtsanwälte Partnerschaftsgesellschaft, Office Munich)

Knorr, Tim (Rittershaus 201511 Lawyer)

 

Organisation Organisation Rittershaus Rechtsanwälte Partnerschaftsgesellschaft, Office Munich
  Group Rittershaus Rechtsanwälte Partnerschaftsgesellschaft mbH
Products Product legal services
  Product 2 LIFE SCIENCES
     

Rittershaus Rechtsanwälte. (11/3/15). "Press Release: Rittershaus Advises CureVac on EUR 100 Million Financing Round". Mannheim.

CureVac AG, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, has raised about EUR 100 million in a private placement. Proceeds from the financing round will be used to further develop CureVac’s clinical pipeline of natural, chemically unmodified mRNA therapeutic and prophylactic product candidates. The new capital will also fund research and clinical development to expand CureVac’s proprietary mRNA platform technology.

In the course of the financing round CureVac changed its corporate legal form to a joint stock company, Aktiengesellschaft (AG), in order to facilitate further international growth on the corporate level.

The new investors, Baillie Gifford, Chartwave Limited, Coppel Family, ELMA and Sigma Group, join the existing investors such as dievini Hopp BioTech holding GmbH & Co. KG, the investment company of SAP-founder Dietmar Hopp, and the Bill & Melinda Gates Foundation.

RITTERSHAUS has been the advisor of CureVac also in this financing round under the leadership of the Mannheim-based partner Christina Eschenfelder. RITTERSHAUS advises CureVac in various fields of activity since 2005 and has counseled the company in 2012 on the largest financing round of any German biotech company until then over an amount of 80 million Euros as well as on the investment of the Bill & Melinda Gates Foundation in spring 2015.


Advisors of CureVac AG

In-House Legal: Dr. Franz Haas, LL.M.

RITTERSHAUS Rechtsanwälte:
Christina Eschenfelder (leading), Dr. Moritz Weber (both Corporate/M&A, Mannheim); Tim Knorr, LL.M. (Corporate M&A, Munich)


RITTERSHAUS Rechtsanwälte is a commercial law firm specialized in advising larger companies with its offices in Mannheim, Frankfurt/Main and Munich. The key area of advisory services is corporate law with particular emphasis on restructuring, M&A-, private equity and venture capital transactions as well as corporate financing, corporate succession and estate planning. Further key areas include banking law and capital markets, employment law, intellectual property law, regulatory and administrative law and IT law.


Contact:

RITTERSHAUS Rechtsanwälte Partnerschaftsgesellschaft mbB
Rechtsanwältin Christina Eschenfelder
Harrlachweg 4, 68163 Mannheim
Tel.: +49-621-4256-229
E-Mail: christina.eschenfelder@rittershaus.net

Mannheim, November 3, 2015

   
Record changed: 2017-04-09

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px



To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top